Among ICU-admitted AMI patients, the initial use of stool softeners or osmotic laxatives was associated with a lower risk of short-term mortality compared with stimulant laxatives. These findings indicate that a more robust and gentle laxative management strategy may have potential clinical value for this high-risk population.
Wang et al. (Thu,) studied this question.